Prediction of prognosis and immunotherapy efficacy based on metabolic landscape in lung adenocarcinoma by bulk, single-cell RNA sequencing and Mendelian randomization analyses

Yong Liu; Xiangwei Zhang; Zhaofei Pang; Yadong Wang; Haotian Zheng; Guanghui Wang; Kai Wang; Jiajun Du

doi:doi:10.18632/aging.205838

← Back

Research Paper Volume 16, Issue 10 pp 8772—8809

Prediction of prognosis and immunotherapy efficacy based on metabolic landscape in lung adenocarcinoma by bulk, single-cell RNA sequencing and Mendelian randomization analyses

Figure 10. Development and evaluation of a prognostic nomogram. (A) Nomogram composed of MPPS, age, stage to predict 1-, 3-, 5-year OS probability. (B) Calibration curves of 1-, 3-, 5-year OS by nomogram. 1- (C), 3- (D), 5- (E) year ROC curves of MPPS, nomogram, age, sex, stage, and treatment type.